title: Resistant hypertriglyceridemia in a patient with high plasma levels of apolipoprotein CII.
authors.forename: P
authors.initials: P
authors.lastname: Fornengo
authors.forename: A
authors.initials: A
authors.lastname: Bruno
authors.forename: R
authors.initials: R
authors.lastname: Gambino
authors.forename: M
authors.initials: M
authors.lastname: Cassader
authors.forename: G
authors.initials: G
authors.lastname: Pagano
mesh_terms: D000328:Adult; D053304:Apolipoprotein C-II; D001056:Apolipoproteins C / Q000097:blood*; D003131:Combined Modality Therapy; D004351:Drug Resistance; D011345:Fenofibrate / Q000627:therapeutic use; D015248:Gemfibrozil / Q000627:therapeutic use; D006801:Humans; D015228:Hypertriglyceridemia / Q000097:blood / Q000178:diet therapy*; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D008297:Male; D017211:Treatment Failure
chemical_list: D053304:Apolipoprotein C-II; D001056:Apolipoproteins C; D000960:Hypolipidemic Agents; D015248:Gemfibrozil; D011345:Fenofibrate